Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
13
Number of overlapping holdings
21.0%
% of XLV's 62 holdings also in HART
17.3%
% of HART's 84 holdings also in XLV
Overlap by Weight
Sector Drift (XLV minus HART)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in XLV |
Weight in HART |
Overlap | |
|---|---|---|---|---|
 |
UNITEDHEALTH GROUP INC | 9.3% | 5.7% | 5.7% |
|
JOHNSON & JOHNSON | 6.8% | 5.4% | 5.4% |
|
ELI LILLY & CO | 12.0% | 4.8% | 4.8% |
|
ABBOTT LABORATORIES | 3.8% | 5.1% | 3.8% |
|
PFIZER INC | 2.8% | 5.3% | 2.8% |
Position Highlights (Non-Overlapping Exposures)
XLV Overweight Relative to HART
|
ELI LILLY & CO | 7.2% |
|
ABBVIE INC | 5.9% |
|
MERCK & CO. INC. | 5.0% |
|
THERMO FISHER SCIENTIFIC INC | 3.9% |
|
INTUITIVE SURGICAL INC | 3.7% |
|
UNITEDHEALTH GROUP INC | 3.6% |
|
DANAHER CORP | 2.9% |
|
AMGEN INC | 2.8% |
|
STRYKER CORP | 2.5% |
|
VERTEX PHARMACEUTICALS INC | 2.3% |
XLV Underweight Relative to HART
|
APPLE INC | -5.6% |
 |
NOVARTIS AG | -5.3% |
 |
ASTRAZENECA PLC | -4.9% |
|
ALPHABET INC. CLASS A | -4.8% |
 |
NOVO NORDISK A/S-B | -4.6% |
 |
SANOFI-AVENTIS | -3.0% |
|
PFIZER INC | -2.5% |
|
NIKE INC -CL B | -2.1% |
|
ELEVANCE HEALTH INC | -1.4% |
|
ABBOTT LABORATORIES | -1.2% |